Progression-free survival (PFS), event-free survival (EFS), and overall... | Download Scientific Diagram
Relationship between event-free survival and overall survival in acute myeloid leukemia: a report from SWOG, HOVON/SAKK, and MRC/NCRI | Haematologica
![Event-free and overall survival following neoadjuvant weekly paclitaxel and dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast. - ppt download Event-free and overall survival following neoadjuvant weekly paclitaxel and dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast. - ppt download](https://images.slideplayer.com/30/9505354/slides/slide_4.jpg)
Event-free and overall survival following neoadjuvant weekly paclitaxel and dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast. - ppt download
![Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data - The Lancet Oncology Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data - The Lancet Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/ecaf029d-bdde-48ff-bec3-78d3aa6f9c00/gr1_lrg.jpg)
Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data - The Lancet Oncology
![Acute myeloid leukemia: survival analysis of patients at a university hospital of Paraná | Hematology, Transfusion and Cell Therapy Acute myeloid leukemia: survival analysis of patients at a university hospital of Paraná | Hematology, Transfusion and Cell Therapy](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S1516848414001455:gr5.jpeg?xkr=ue/ImdikoIMrsJoerZ+w92xcqUtYYCc6yiYRjTD2AR1aFJOKb7qLd+WBf18Ptk/O8dVG5SMqADZji5skBxdmL83IXxo36SddaR63DsSq89mcTB3Hj+ztPQGA6zqULHnBHpT4s9P3G9ZiXVHfJK3hkMt6mGddu7dsrxAXvHUh2DAVXS65CzzQbSvmIJw+LHH0O4cvudJZ1sLq1lL32NJzmn7aCG/A8lqqCCpYSf7gw6Yqtabyu1B9BQu3aUSQbWle/cVVQFMzbA7D0xvmQlEfSn1+4DQxS/Nh1yR4KMO+RokNoQNIIr1UbZEoIivRQdSk)
Acute myeloid leukemia: survival analysis of patients at a university hospital of Paraná | Hematology, Transfusion and Cell Therapy
![Frontiers | Evaluation of Event-Free Survival Surrogating Overall Survival as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal Adenocarcinoma Frontiers | Evaluation of Event-Free Survival Surrogating Overall Survival as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal Adenocarcinoma](https://www.frontiersin.org/files/Articles/835389/fonc-12-835389-HTML/image_m/fonc-12-835389-g002.jpg)
Frontiers | Evaluation of Event-Free Survival Surrogating Overall Survival as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal Adenocarcinoma
![Event-Free Survival As a Surrogate Endpoint for Overall Survival in Previously Untreated Acute Myeloid Leukemia: An Individual Patient-Level Analysis of Multiple Randomized Trials (Alliance A151614) - ScienceDirect Event-Free Survival As a Surrogate Endpoint for Overall Survival in Previously Untreated Acute Myeloid Leukemia: An Individual Patient-Level Analysis of Multiple Randomized Trials (Alliance A151614) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S000649711937435X-fx1.jpg)
Event-Free Survival As a Surrogate Endpoint for Overall Survival in Previously Untreated Acute Myeloid Leukemia: An Individual Patient-Level Analysis of Multiple Randomized Trials (Alliance A151614) - ScienceDirect
![Event-free survival (EFS) and overall survival (OS) according to risk... | Download Scientific Diagram Event-free survival (EFS) and overall survival (OS) according to risk... | Download Scientific Diagram](https://www.researchgate.net/publication/339340909/figure/fig4/AS:958472770310157@1605529124751/Event-free-survival-EFS-and-overall-survival-OS-according-to-risk.png)
Event-free survival (EFS) and overall survival (OS) according to risk... | Download Scientific Diagram
![Kaplan-Meier plot of event-free survival (EFS) and overall survival... | Download Scientific Diagram Kaplan-Meier plot of event-free survival (EFS) and overall survival... | Download Scientific Diagram](https://www.researchgate.net/publication/312303406/figure/fig1/AS:625531582177282@1526149759970/Kaplan-Meier-plot-of-event-free-survival-EFS-and-overall-survival-OS-A-EFS-in-all.png)
Kaplan-Meier plot of event-free survival (EFS) and overall survival... | Download Scientific Diagram
![Frontiers | Evaluation of Event-Free Survival Surrogating Overall Survival as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal Adenocarcinoma Frontiers | Evaluation of Event-Free Survival Surrogating Overall Survival as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal Adenocarcinoma](https://www.frontiersin.org/files/Articles/835389/fonc-12-835389-HTML/image_m/fonc-12-835389-g003.jpg)
Frontiers | Evaluation of Event-Free Survival Surrogating Overall Survival as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal Adenocarcinoma
![Kaplan-Meier curve for overall survival (OS) and event-free survival (EFS) according to the expression of CD30 and IPI. Kaplan-Meier curve for overall survival (OS) and event-free survival (EFS) according to the expression of CD30 and IPI.](https://s3-eu-west-1.amazonaws.com/ppreviews-plos-725668748/2068155/preview.jpg)
Kaplan-Meier curve for overall survival (OS) and event-free survival (EFS) according to the expression of CD30 and IPI.
![A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer - eClinicalMedicine A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer - eClinicalMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/89e27cb7-3ddf-466e-b549-45d5db1c5526/gr2_lrg.jpg)
A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer - eClinicalMedicine
![Non-anthracycline-containing docetaxel and cyclophosphamide regimen is associated with sustained worse outcome compared with docetaxel, anthracycline and cyclophosphamide in neoadjuvant treatment of triple negative and HER2-positive breast cancer ... Non-anthracycline-containing docetaxel and cyclophosphamide regimen is associated with sustained worse outcome compared with docetaxel, anthracycline and cyclophosphamide in neoadjuvant treatment of triple negative and HER2-positive breast cancer ...](http://article.cjcrcn.org/fileZGAZYJ/journal/article/zgazyj/2016/6/PIC/cjcr-28-6-561-g002.jpg)
Non-anthracycline-containing docetaxel and cyclophosphamide regimen is associated with sustained worse outcome compared with docetaxel, anthracycline and cyclophosphamide in neoadjuvant treatment of triple negative and HER2-positive breast cancer ...
![New Prediction Model for 5-year Event-free Survival Rate from Ventricular Arrhythmia | Radcliffe Cardiology New Prediction Model for 5-year Event-free Survival Rate from Ventricular Arrhythmia | Radcliffe Cardiology](https://assets.radcliffecardiology.com/s3fs-public/article/2021-04/figure2-new-prediction-model.png)
New Prediction Model for 5-year Event-free Survival Rate from Ventricular Arrhythmia | Radcliffe Cardiology
![Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive](https://archive.cancerworld.net/wp-content/uploads/2015/10/RCT-of-Letrozole-in-Post-menopausal-breast-cancer.jpg)
Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive
![OP0294 SJÖGREN'S SYNDROME ASSOCIATED LYMPHOMAS: CLINICAL DESCRIPTION AND 10-YEAR SURVIVAL | Annals of the Rheumatic Diseases OP0294 SJÖGREN'S SYNDROME ASSOCIATED LYMPHOMAS: CLINICAL DESCRIPTION AND 10-YEAR SURVIVAL | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/80/Suppl_1/180/F1.large.jpg)
OP0294 SJÖGREN'S SYNDROME ASSOCIATED LYMPHOMAS: CLINICAL DESCRIPTION AND 10-YEAR SURVIVAL | Annals of the Rheumatic Diseases
![Event-free survival at 24 months is a robust surrogate endpoint for long-term survival in pediatric, adolescent, and adult T cell lymphoblastic lymphoma | SpringerLink Event-free survival at 24 months is a robust surrogate endpoint for long-term survival in pediatric, adolescent, and adult T cell lymphoblastic lymphoma | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00277-020-04195-z/MediaObjects/277_2020_4195_Fig4_HTML.png)
Event-free survival at 24 months is a robust surrogate endpoint for long-term survival in pediatric, adolescent, and adult T cell lymphoblastic lymphoma | SpringerLink
Blood and tissue biomarker analysis in dogs with osteosarcoma treated with palliative radiation and intra-tumoral autologous natural killer cell transfer | PLOS ONE
![Relationship between presarcopenia and event occurrence in patients with primary hepatocellular carcinoma | Scientific Reports Relationship between presarcopenia and event occurrence in patients with primary hepatocellular carcinoma | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-67147-7/MediaObjects/41598_2020_67147_Fig1_HTML.png)
Relationship between presarcopenia and event occurrence in patients with primary hepatocellular carcinoma | Scientific Reports
![Improved Event-Free Survival and Higher Incidence of Early Fever Associated with Mismatches at HLA-DRB1 after Nonmyeloablative HLA-Haploidentical Transplantation - Biology of Blood and Marrow Transplantation Improved Event-Free Survival and Higher Incidence of Early Fever Associated with Mismatches at HLA-DRB1 after Nonmyeloablative HLA-Haploidentical Transplantation - Biology of Blood and Marrow Transplantation](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/7b390ded-6c92-4578-8079-4e858709eaf2/ybbmt54468-fig-0001_lrg.jpg)